CINCINNATI, March 25, 2016 -- Statman Harris & Eyrich, LLC ("SH&E") announces that a class action complaint has been filed against The Honest Company (the “Company”) for allegedly falsely labeling some of its products.
The Complaint alleges that Company’s Honest Laundry Detergent, Honest Dish Soap, and Honest Multi-Surface Cleaner, are advertised as natural and free of harmful chemicals such as sodium lauryl sulfate (“SLS)”, a known skin irritant, and marketed as being a gentler alternative to harsh chemicals like SLS since they contained sodium coco sulfate (“SCS”), a coconut based cleanser
However the complaint asserts that these representations are “misleading in the extreme” because SCS is an irritating surfactant just as SLS is, and in fact, SLS is a major component of SCS. As a result, the complaint alleges that the Company “Honest is deceiving customers by representing that they can avoid SLS by using the SCS formulation in the SCS products, and is charging a premium for the ostensibly safer SCS products.”
The complaint was filed by another firm in the United States District Court for Central District of California - Case No. 2:16-CV-01835.
Ohio consumers who have purchased any of these products cited above are encouraged to contact Sylvie Derrien at (513) 345-1740 or at [email protected] for further information about their legal rights, without any cost or obligation.
Statman, Harris & Eyrich, LLC, which has significant experience in consumer and securities fraud class actions and derivative litigation, has offices in Chicago, Illinois; Cincinnati, Ohio; Dayton, Ohio; and Detroit, Michigan. www.statmanharris.com Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Sylvie Derrien, Esq. Statman, Harris & Eyrich, LLC 441 Vine Street, Suite 3700 Cincinnati, Ohio 45202 Phone: (513) 345-1740 Email: [email protected]


Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 



